ALLISON WHITT: Open Payments
NPI 1689265647 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 29 payments from 12 companies in 2025. Trend: 2023 $767 · 2024 $672 · 2025 $1,039
Food & beverage: $944Education: $95
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $206 |
| Fennec Pharmaceuticals, Inc. | 1 | $202 |
| PFIZER INC. | 4 | $117 |
| SEAGEN INC. | 1 | $95 |
| ABBVIE INC. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Eisai Inc. | 3 | $65 |
| Integra LifeSciences Corporation | 2 | $52 |
| Baxter Healthcare | 1 | $45 |
| Caris MPI, Inc. | 1 | $37 |
Products named: LYNPARZA, Fyarro, TIVDAK, ELAHERE, KEYTRUDA, Lenvima, CODMAN CERTAS, FLOSEAL.
Industry payments across VA — which companies pay providers there.
